Clinical trial
A Prospective Clinical Study to Evaluate the Safety and Clinical Feasibility of the MitraFix® Transcatheter Mitral Valve System
NCT07501234 is registered in ClinicalTrials.gov with Mitrassist Lifesciences Limited Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Clinical Study to Evaluate the Safety and Clinical Feasibility of the MitraFix® Transcatheter Mitral Valve System
- Lead sponsor
- Mitrassist Lifesciences Limited Co., Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 23, 2026
- Completion date
- October 23, 2028
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitral regurgitation (mr)